News
COR
283.00
-0.27%
-0.77
Invesco Discovery Mid Cap Growth Fund Q1 2025 Commentary
Seeking Alpha · 23h ago
Cencora Inc. stock underperforms Thursday when compared to competitors
MarketWatch · 3d ago
Hartford Healthcare Fund Q1 2025 Commentary
Seeking Alpha · 3d ago
Cencora price target raised to $313 from $288 at Morgan Stanley
TipRanks · 3d ago
Cencora price target raised to $350 from $314 at Baird
TipRanks · 3d ago
Cencora’s Mixed Performance: Strong U.S. Growth Offset by International Challenges and Strategic Caution
TipRanks · 3d ago
Evercore ISI Keeps Their Buy Rating on Cencora (COR)
TipRanks · 4d ago
Cencora, Inc. Reports Strong Q2 2025 Results
TipRanks · 4d ago
Cencora’s Earnings Call: Strong Growth Amid Challenges
TipRanks · 4d ago
Cencora’s Strong U.S. Performance and Growth Prospects Justify Buy Rating
TipRanks · 4d ago
Cencora Inc. stock outperforms competitors on strong trading day
MarketWatch · 4d ago
Cencora, Inc. Reports Financial Results for the Quarter Ended March 31, 2025
Press release · 4d ago
Stocks Finish Higher as Chip Stocks Rally
Barchart · 4d ago
Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth
Seeking Alpha · 4d ago
Early notable gainers among liquid option names on May 7th
TipRanks · 4d ago
Cencora declares $0.55 dividend
Seeking Alpha · 4d ago
Cencora Reports Strong Q2 2025 Financial Results
TipRanks · 4d ago
Cencora raises FY25 adjusted EPS view to $15.70-$15.95 from $15.30-$15.60
TipRanks · 4d ago
Stocks Turn Mixed Ahead of FOMC Meeting Results
Barchart · 4d ago
Here are the major earnings before the open tomorrow
Seeking Alpha · 5d ago
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
More
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Recently
Symbol
Price
%Change